Chief Natural Plant Active Ingredient Scientist

Research Focus:
Dedicated to fundamental and applied research on anti-inflammatory and immunomodulatory drugs, with particular expertise in the use of plant extracts for skin repair. Has conducted groundbreaking research on skin damage caused by various inflammatory conditions.

Honors and Awards:

• Published representative papers in journals including Journal of Medicinal Chemistry, Chemistry & Biology, and Phytomedicine.

• Led 5 National Natural Science Foundation projects.

• Headed 1 Shanghai Pujiang Talent Program project.

• Directed 1 sub-project of the National "Major New Drug Discovery" Science and Technology Major Specialized Project.

• Managed 1 sub-project of the "12th Five-Year" Military Medical Science and Technology Key Project.

• Oversaw 1 sub-project of the "12th Five-Year" Military Special Drug Discovery Technology Platform Major Specialized Project.

• Received 1 Shanghai Science and Technology Progress First Prize.

• Awarded 1 Military Science and Technology Progress Second Prize.

• Earned 1 Hebei Province Science and Technology Progress Second Prize and 1 Fujian Province Science and Technology Progress Second Prize.

• Honored with 1 Chinese Medical Science and Technology Award.

Chief Microbial Fermentation Application Scientist

Research Focus:

1. Metabolic Engineering: Analysis, regulation, and breeding of microbial metabolic processes. Applied to the preparation and development of genetically engineered protein drugs and fermentation processes for other biotechnological pharmaceuticals.

2. Biocatalysis and Biotransformation: Screening and characterization of novel microbial enzyme sources; industrial applications of biocatalytic reactions.

With extensive experience in antibiotic fermentation, production, and management of biological and biochemical drugs, as well as drug research and development, the scientist has led or participated in multiple research projects through theoretical and applied studies, focusing on unlocking their potential for industrial applications. Key projects include: enzymatic resolution of chiral amino acids; fermentation of genetically engineered strains for the production of adenosylmethionine; and biotransformation for the preparation of ganglioside GM1.

Honors and Awards:

• Published over ten papers in indexed domestic and international journals.

• Filed three national invention patent applications.

• Received two provincial/ministerial-level Third Prizes for Scientific and Technological Progress.

• Conducted a one-year visiting scholarship at the School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, USA, in August 2012, while working at the East China University of Science and Technology, School of Biotechnology, and the State Key Laboratory of Bioreactor Engineering.

• Led or participated in multiple Ministry of Science and Technology "863" projects and National Natural Science Foundation projects.

• Research achievements have received numerous Shanghai municipal and national-level awards, with multiple results successfully industrialized.

Chief Carrier Technology Scientist

Research Focus:
Primary research areas include targeted drug delivery systems, injectable delivery systems for poorly soluble drugs, and controlled-release drug delivery systems. With years of experience in the development of novel drug formulations, technologies, and excipients, he has extensive expertise in liposomes and intravenous emulsions. He possesses unique theoretical and practical knowledge in drug delivery systems for poorly soluble compounds, particularly micellar systems and oral solid formulations. By applying carrier technology to poorly soluble drugs, he enhances transdermal absorption of active ingredients, reduces moisture loss, repairs damaged human cell membranes, improves the stability of active substances, and facilitates their application.

Honors and Awards:

• Published multiple academic papers in international journals such as Biomaterials and International Journal of Pharmaceutics.

• Led several research projects at the municipal, military, and national levels.

• Received a Third Prize for Military Science and Technology Progress.

• Filed over 20 domestic and international patent applications, with multiple patents granted.

• Awarded a Third Prize for Shanghai Patent Invention.

• Supervised multiple graduate students whose theses received honors such as Shanghai Outstanding Master's Thesis and PLA Outstanding Master's Thesis.

Ma Xia, Professor at the School of Perfume and Aroma Technology and Engineering, Shanghai Institute of Technology. Her main work focuses on teaching and research in the fields of fermentation of new biological materials and their applications, as well as functional fermented foods. Since 2011, she has served as the academic leader in biology and has long been responsible for teaching the "Biochemistry" course, co-authoring professional textbooks. She has led over ten provincial and ministerial-level projects. In 2021, as the principal investigator, she undertook a scientific instrument project under Shanghai's "Science and Technology Innovation Action Plan." Her research achievements include studies on the bioactivity of tremella polysaccharide-metal ion complexes. She has received multiple honors, including the Shandong Provincial Science and Technology Progress Award and the Shanghai Outstanding Invention Gold Award.

Ding Xiaolei, Specially Appointed Professor and Doctoral Supervisor at Shanghai University School of Medicine, primarily focuses on molecular mechanisms of skin tissue regeneration, aging, and disease. His research team systematically investigates the role of the mTOR signaling pathway in skin development, repair, and disease, revealing its critical regulatory function in wound epithelialization. Professor Ding has led research projects including the National Natural Science Foundation of China General Program and Shanghai Innovation Talent Program, with findings published in international journals such as Cell Metabolism and Nature Communications. He has received multiple international awards, including the 2017 European Society for Dermatological Research (ESDR) Young Investigator Award and the 2020 La Roche-Posay ROSA Research Award

Guan Yongmei, Professor, Doctoral Supervisor. Selected for the Jiangxi Provincial High-Level and High-Skilled Leading Talent Program and the Jiangxi Administration of Traditional Chinese Medicine's Youth Talent Training Program in TCM. Serves as a Council Member of the World Federation of Chinese Medicine Societies (WFCMS) Committee on Chinese Medicinal Pharmacy, and as a Council Member of the WFCMS Professional Committee on Medicinal Diet and Therapy. Former Visiting Scholar at Beijing University of Chinese Medicine and the University of Adelaide, Australia. Primarily engaged in teaching and research in the fields of Chinese Medicinal Formulations, Pharmaceutics, and Chinese Materia Medica. Has led or participated in 7 national-level research projects. Published textbooks and monographs such as Pharmaceutical Excipients Science, Practical Handbook of Pediatric Chinese Patent Medicines, Medicinal Diet and Therapy Science, and Chinese Medicinal Health Preservation and Dietetics, and has authored over 60 articles in domestic and international journals.

Permanent Member of the Chinese Society of Biotechnology

Member of the Chinese Society for Microbiology